Cytotoxic activity of proteins isolated from extracts of Corydalis cava tubers in human cervical carcinoma HeLa cells
© Nawrot et al; licensee BioMed Central Ltd. 2010
Received: 5 June 2010
Accepted: 17 December 2010
Published: 17 December 2010
Corydalis cava Schweigg. & Koerte, the plant of numerous pharmacological activities, together with the studied earlier by our group Chelidonium majus L. (Greater Celandine), belong to the family Papaveraceae. The plant grows in Central and South Europe and produces the sizeable subterraneous tubers, empty inside, which are extremely resistant to various pathogen attacks. The Corydalis sp. tubers are a rich source of many biologically active substances, with the extensive use in European and Asian folk medicine. They have analgetic, sedating, narcotic, anti-inflammatory, anti-allergic and anti-tumour activities. On the other hand, there is no information about possible biological activities of proteins contained in Corydalis cava tubers.
Nucleolytic proteins were isolated from the tubers of C. cava by separation on a heparin column and tested for DNase activity. Protein fractions showing nucleolytic activity were tested for cytotoxic activity in human cervical carcinoma HeLa cells. Cultures of HeLa cells were conducted in the presence of three protein concentrations: 42, 83 and 167 ng/ml during 48 h. Viability of cell cultures was appraised using XTT colorimetric test. Protein fractions were separated and protein bands were excised and sent for identification by mass spectrometry (LC-ESI-MS/MS).
The studied protein fractions showed an inhibiting effect on mitochondrial activity of HeLa cells, depending on the administered dose of proteins. The most pronounced effect was obtained with the highest concentration of the protein (167 ng/ml) - 43.45 ± 3% mitochondrial activity of HeLa cells were inhibited. Mass spectrometry results for the proteins of applied fractions showed that they contained plant defense- and pathogenesis-related (PR) proteins.
The cytotoxic effect of studied proteins toward HeLa cell line cells has been evident and dependent on increasing dose of the protein. The present study, most probably, represents the first investigations on the effect of purified PR proteins from tuber extracts of a pharmacologically active plant on cell lines.
Plants from the family Papaveraceae are frequently used in traditional medicine as a remedy for treatment of several diseases. Such plants include Corydalis cava Schweigg. & Koerte; syn. Corydalis bulbosa (L.) Pers. non (L.) DC. and Chelidonium majus L. studied earlier by our group (Greater Celandine). The two species are closely related and belong to order Papaverales [1, 2]. Milky sap as well as extracts of the whole Chelidonium majus plant has been used to treat papillae, warts, condylomae, which are a visible effect of human papilloma virus (HPV) infection. It has also been found that they have antimicrobial, antitumor, anti-inflammatory, antifungal, and fungistatic properties . The tuber of Corydalis sp. contains isoquinoline alkaloids of apomorphine type, e.g. bulbocapnine, corydaline, which manifest analgetic, sedating and narcotic effects [4–7]. The plant has been used for the treatment of severe neurological disorders and mental diseases. It was also used in cases of asomnia, tension and anxiety conditions . Some species of Corydalis are used in East Asia as analgetic drugs: in the traditional Chinese medicine, the species of Corydalis yanhusho was used to alleviate post-traumatic, colic, abdominal and menstrual pains . Moreover, extracts of the same species showed anti-cancerous metastasis effect in vitro. Anti-tumour activity of Corydalis species was also reported for Korean Corydalis turtschaninovii, which is effective for the treatment of inflammatory, allergic diseases and tumours . Isoquinoline alkaloids contained in alcohol extracts of tubers in many species of Corydalis, affect metabolism of neurotransmitters . Active compounds in such extracts include alkaloids, such as bulbocapnine, corydaline and corydine . The similar curing properties of Chelidonium majus milky sap were attributed mainly to alkaloids, such as chelidonine, sanguinarine, berberine, coptosine, chelerythrine, and also several flavonoids and phenolic acids . However, different findings show that all of them may be potentially toxic for human either alone or in combination [13, 14].
Our earlier studies have shown that biological activity of Chelidonium majus milky sap may be related to its protein content. The majority of the identified proteins can be linked to direct and indirect stress and defense reactions, e.g. against different pathogens [15–17]. We have recently discovered that purified plant proteins from Chelidonium majus milky sap with nucleolytic activity, which probably belong to pathogenesis-related (PR) protein family, are capable of inducing apoptosis in human cervical cancer HeLa cells .
Therefore, the objective of our study was to evaluate the effect of purified proteins from extracts of Corydalis cava tubers with nucleolytic activity on HeLa tumour cells and to identify the protein content of such purified fractions using tandem mass spectrometry.
Corydalis cava plants were collected during 2007 and 2008 in the neighbourhood of Poznań, Poland, during flowering, in April. A voucher specimen was deposited at the Department of Molecular Virology, Faculty of Biology, Adam Mickiewicz University in Poznan, Poland.
The protein extract was prepared from tubers, dissolved in 0.1 M Tris-Cl buffer, pH 8.0, containing 10% glycerol (extract : buffer ratio was 1:1). The tuber extract (50% v/v) samples were separated into a supernatant, and a pellet fraction, by centrifugation at 12000 rpm for 20 min at 4°C as described in the protocol , with modifications. Supernatants were stored at -20°C for further analysis. Protein concentration was determined according to Lowry et al. .
Isolation and purification of proteins
For isolation and purification of proteins, crude extracts from C. cava tubers collected in April were used. About 0.5-μg protein was loaded on HT Heparin column (GE Healthcare) (0.7 × 2.5 cm) equilibrated with 0.1 M Tris-HCl, pH 8.0, 10% glycerol. The column was eluted with a linear gradient of 0 to 2 M NaCl in the same buffer. The absorbance at 280 nm and DNase activity of all fractions (volume 1 ml) were determined.
Analysis by SDS-PAGE
In order to verify the protein composition of chromatographic fractions, sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was carried out in a slab mini-gel apparatus according to Laemmli 1970 , using 10% polyacrylamide as the separating gel and 5% polyacrylamide as the stacking gel. The proteins were reduced by heating them at 100°C in the presence of 2-mercaptoethanol for 5 min. After SDS-PAGE, the gels were fixed and stained with silver according to Shevchenko et al. .
In-gel nuclease assay
An in-gel DNase assay was performed according to Thelen and Northcote , with modifications . For in-gel DNase assay, C. cava tuber extracts or fractions after purification were dissolved in SDS-PAGE sample buffer without a reducing agent, incubated at 37°C for 10 min, and subjected to SDS-PAGE in 10% polyacrylamide gel containing denatured calf thymus DNA (40 μg/ml). After the electrophoresis and removal of SDS, the gels were washed with reaction buffer (10 mM Tris-HCl, pH 8.0, containing 10 mM CaCl2). DNase activity was visualized by staining the gel with ethidium bromide.
Cell culture and viability assay
HeLa cells were cultured in RPMI 1640 supplemented with 5% FCS, 2 mmol/l L-glutamine, 100 μg/ml streptomycin and 100 U/ml penicillin. Viability of cell cultures was appraised using XTT colorimetric test, based on a dynamics of XTT (tetrazoline 2,3-bis(2-methoxy-4-nitro-5-sulfofenylo)-2H-5-carboxyanilide) stain reduction by viable cells with the formation of a colored product. Intensity of the fluorescence was measured at the wavelength of 450 nm. Percentage of mitochondrial metabolism activity inhibition was calculated according to the following equation: 100-(OD drug treated cells - OD medium alone/OD untreated cells-OD medium alone*100). Each experiment was conducted independently in 8 cultures and in each culture at least 200 cells were scored. Statistical analysis of the results involved the t-test for unpaired data using the STATISTICA ver.6.1 software. P value < 0.05 was considered to represent threshold of significance.
Stained protein bands were excised from the gel and analyzed by liquid chromatography coupled to mass spectrometer in the Laboratory of Mass Spectrometry, Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, Poland. Samples were concentrated and desalted on RP-C18 precolumn (LC Packings, UK) and further peptide separation was achieved in a nano-HPLC RP-C18 column (LC Packings, 75 mM i.d.) of a UltiMate nano-HPLC system, using a 50-min linear acetonitrile gradient. Column outlet was directly coupled to Finningan Nanospray ion source of LTQ-FT (Thermo, USA) mass spectrometer working in the regime of data dependent MS to MS/MS switch. An electrospray voltage of 1500 V and a cone voltage of 30 V were used.
MS/MS data analysis
The data were analysed automatically by database matching against the NCBInr protein database (NCBI, Bethesda, USA) with a Viridiplantae filter, using the MASCOT database search engine (Matrix science, London, UK; http://www.matrixscience.com) .
Isolation and purification of proteins from Corydalis cava tuber extracts on a heparin column
In order to evaluate if biological activity of Corydalis tuber extracts is related to the proteins contained in them, the proteins of nucleolytic activity were isolated from the tubers by purification on a HT Heparin column (Figure 1A) using ÄKTA Explorer™ chromatographic system (Amersham Biosciences). Following the application of the extract to the column (0.7 × 2.5 cm), molecules which did not bind to the column were eluted using elution buffer (buffer A: 100 mM Tris, pH 8.0, 10% glycerol). The first eight fractions of 1.5 ml each represented the flow-through fractions. The subsequent fractions were eluted using a linear gradient of NaCl (from 0 to 2 M) (19 fractions of 1 ml each). In all the fractions, absorbance was measured at 280 nm (Figure 1A), indicating the presence of purified proteins in fractions 16-18. Protein fractions purified on heparin column were tested for DNase activity using in-gel DNase assay (Figure 1B) according to Thelen and Northcote . Nucleolytic activity was demonstrated in fraction numbers 16, 17 and 18. All the fractions were also separated in SDS-containing polyacrylamide gel (SDS-PAGE), which was stained with silver according to Shevchenko et al.  (Figure 1C). Fraction numbers 16 and 17 each contained five protein bands of molecular weights (MW) approx. 30, 32, 35, 38 and 68 kDa, while the fraction number 18 contained an additional fraction of MW around 140 kDa.
Analysis of mitochondrial activity of HeLa cells
Mitochondrial activity inhibition in neoplastic HeLa cells under the effect of purified protein fractions from extracts of C. cava tubers.
Protein concentration [ng/ml]
Mean value of HeLa cells inhibition [%]
Standard deviation [%]
The cytotoxic effect of studied proteins in relation to HeLa cell line was clearly marked and it depended on the applied dose of protein: the most pronounced effect was obtained with protein fractions administered at the highest concentration (167 ng/ml), while at the intermediate concentration (83 ng/ml), the effect was appropriately lower compared to the highest concentration. Fraction 18 exerted the highest cytotoxic effect at the concentration of 167 ng/ml: 43.45 ± 3% cells underwent mitochondrial activity inhibition (Table 1). Protein fractions at the lowest protein concentration (42 ng/ml) manifested the least pronounced cytotoxic effect (e.g., fraction 16: 4.55 ± 3.5%, table 1). In the experiments, the control was provided by the pure elution buffer (0.1 M Tris, 10% glycerol), added to HeLa cells at the concentration of 26.7 μl/ml, which did not exert any effect on mitochondrial activity of HeLa cells.
Identification of proteins in purified fractions by mass spectrometry
The protein bands were numbered 1 to 6 (Figure 1C), excised from the gel stained with silver  and sent for identification by mass spectrometry (LC-ESI-MS/MS) at the Laboratory of Mass Spectrometry, Institute of Biochemistry and Biophysics, Polish Academy of Sciences (IBB PAN) in Warsaw, Poland. The data was analyzed using MASCOT (http://www.matrixscience.com).
Defense-related proteins identified in fractions after purification of nucleases from extracts of Corydalis cava tubers using LC-ESI-MS/MS.
No. of protein banda)
Mol. mass (Da)f)
Sequence coverage (%)h)
1, 2, 3, 4,
peroxidase [Nicotiana tabacum] (PR-9)
heat shock protein 70 [Chlorella zofingiensis]
pectinesterase [Phaseolus vulgaris]
SODP_PETHY Superoxide dismutase (ISS) [Ostreococcus tauri]
GRP-like protein 2 [Gossypium hirsutum]
disease resistance protein (TIR-NBS-LRR class), putative [Arabidopsis thaliana]
ribosomal protein S12 [Mesostigma viride]
DNA-binding protein [Zea mays]
chloroplast nucleoid DNA-binding protein-related [Arabidopsis thaliana]
RPP13-like protein [Arabidopsis arenosa]
Table 2 lists identified defense-related proteins with plant species in which the proteins were detected as well as protein scores and sequence coverages. The number of compatible peptides for individual results ranged between 1 and 43, sequence coverage in a single case reached the maximum value of 26%. In the Table 2, numbers of protein bands were indicated in which particular proteins were identified (Figure 1C).
Plants that belong to family Papaveraceae, like Greater Celandine (Chelidonium majus L.) and Corydalis cava Schweigg. & Koerte, are a rich source of various biologically active substances with strong pharmacological activity. The mechanism of this activity is still unknown, but very important compounds are the proteins contained in the plants. Our earlier studies showed that biological activity of Chelidonium majus milky sap may be related to its protein content. The protein fractions which contained two nucleases induced apoptosis in human cervical cancer HeLa cells .
Most probably, the present study represents the first investigations on the effect of purified PR proteins from tuber extracts of a pharmacologically active plant on cell lines. The cytotoxic effect of studied proteins toward HeLa cell line cells has been evident and dependent on increasing dose of the protein.
Results of protein identification in fractions from purification of C. cava tuber extracts using LC-ESI-MS/MS analysis have shown that proteins contained in bands of fractions 16-18 belong to plant pathogenesis- and defense-related proteins, indirectly or directly involved in plant defense reactions against stresses of various kind. Many of them belong to the PR protein family involved in plant defense against the pathogen attack. The family includes 17 protein classes of variable activities . C. cava tubers are exposed to the attack of fungal, viral, bacterial and other pathogens during the entire vegetation season as well as during winter time . Accumulation of high number and variability of defense proteins in tubers together with several secondary metabolites, such as isoquinoline alkaloids, provides an effective and long-time protection against attack of pathogens. Moreover, defense-related proteins contained in C. cava tubers resemble 21 proteins identified earlier by our group in Chelidonium majus milky sap .
The studies represent preliminary demonstration of the effect exerted by tuber proteins from a plant of pharmacological significance on cells of a tumour cell line. The investigated protein fractions comprise a mixture of plant defense-related proteins. In subsequent studies, an effort will be made to isolate the individual proteins and examine their effect on tumour cells individually and in combinations as well. Nevertheless, the synergistic action of all the compounds present in plant protein extracts is very important for their activity. Many effective and extensively studied compounds of plant origin are, in fact, crude protein mixtures, such as phytotherapeutical drug bromelain, which is crude, aqueous extract from the stems and immature fruits of pineapples (Ananas comosus from the family Bromeliaceae), constituting a complex mixture of different thiol-endopeptidases and other components such as phosphatases, glucosidases, peroxidases, cellulases, glycoproteins, carbohydrates and several proteinase inhibitors . Also, Viscum album L. extracts (VAE, European mistletoe) are composed of pharmacologically relevant compounds like: mistletoe lectins (ML I, II and III), viscotoxins and other low molecular proteins, VisalbCBA (Viscum album chitin-binding agglutinin), oligo- and polysaccharides, flavonoids, vesicles, triterpene acids, and others. Whole VAE as well as several of the compounds are cytotoxic and the mistletoe lectins have strong apoptosis-inducing effects .
Although the mechanism of presented activity of C. cava proteins is unknown, their defensive role for the plant could be very important. Many plant defense-related proteins belong to small (14-40 amino acids), linear, cationic peptides. These peptides have membrane lytic properties and potent activity against a broad spectrum of microorganisms. They organize into ordered secondary structures (α-helix and β-sheet) in the membrane . Above a threshold concentration, peptides disturb the cell membrane and cause cell death due to membrane disintegration .
Presented studies confirm that biological activity of C. cava extracts may also be related to proteins contained in the extracts. For possible further applications, the biologically active plant proteins should be separated from alkaloids and other secondary metabolites, which in higher doses might be toxic . The studies represent preliminary demonstration of the effect exerted by tuber proteins from a plant of pharmacological significance on cells of a tumour cell line. In the subsequent studies, an effort will be made to isolate the individual proteins and examine their effect on tumour cells individually and in combinations.
This work was financed by the AMU-UMS-ULS inter-universities grant no. 512-00-073 (2009, Poznań, Poland) and Polish Minister of Science and Higher Education grant no. 0872/B/P01/2008/34.
- Cronquist A: An Integrated System of Classification of Flowering Plants. 1981, New York, Columbia University PressGoogle Scholar
- Reveal JL: System of Classification. PBIO 250 Lecture Notes: Plant Taxonomy. 1999, Department of Plant Biology, University of MarylandGoogle Scholar
- Colombo ML, Bosisio E: Pharmacological activities of Chelidonium majus L. (Papaveraceae). Pharm Res. 1996, 33: 127-134. 10.1006/phrs.1996.0019.View ArticleGoogle Scholar
- Rueffer M, Bauer W, Zenk MH: The formation of corydaline and related alkaloids in Corydalis cava in vivo and in vitro. Can J Chem. 1994, 72: 170-175. 10.1002/cjce.5450720128.View ArticleGoogle Scholar
- Hänsel R, Sticher O: Pharmakognosie-Phytopharmazie. 2004, Heidelberg, Springer VerlagGoogle Scholar
- Freudenreich O: Ocular side effects associated with dietary supplements and herbal medicines. Drugs Today. 2005, 41: 537-10.1358/dot.2005.41.8.896835.View ArticleGoogle Scholar
- Cheng ZH, Guo Y-L, Wang H-Y, Chen G-Q: Qualitative and quantitative analysis of quaternary ammonium alkaloids from Rhizoma Corydalis by matrix-assisted laser desorption/ionization Fourier transform mass spectrometry coupled with a selective precipitation reaction using Reinecke salt. Anal Chim Acta. 2006, 555: 269-277. 10.1016/j.aca.2005.09.003.View ArticleGoogle Scholar
- Gao JL, Shi JM, He K, Zhang QW, Li SP, Lee SM, Wang YT: Yanhusuo extract inhibits metastasis of breast cancer cells by modulating mitogen-activated protein kinase signaling pathways. Oncol Rep. 2008, 20: 819-824.PubMedGoogle Scholar
- An HJ, Rim HK, Chung HS, Choi IY, Kim NH, Kim SJ, Moon PD, Myung NY, Jeong HJ, Jeong CH, Chung SH, Um JY, Hong SH, Kim HM: Expression of inducible nitric oxide synthase by Corydalis turtschaninovii on interferon-gamma stimulated macrophages. J Ethnopharmacol. 2009, 122: 573-578. 10.1016/j.jep.2008.12.030.View ArticlePubMedGoogle Scholar
- Schäfer HL, Schäfer H, Schneider W, Elstner EF: Sedative action of extract combinations of Eschscholtzia californica and Corydalis cava. Arzneimittelforschung. 1995, 45: 124-126.PubMedGoogle Scholar
- Adsersen A, Kjølbye A, Dall O, Jäger AK: Acetylcholinesterase and butyrylcholinesterase inhibitory compounds from Corydalis cava Schweigg. & Kort. J Ethnopharmacol. 2007, 113: 179-182. 10.1016/j.jep.2007.05.006.View ArticlePubMedGoogle Scholar
- Tome F, Colombo ML: Distribution of alkaloids in Chelidonium majus and factors affecting their accumulation. Phytochemistry. 1995, 40: 37-39. 10.1016/0031-9422(95)00055-C.View ArticleGoogle Scholar
- Benninger J, Schneider HT, Schuppan D, Kirchner T, Hahn EG: Acute hepatitis induced by greater celandine (Chelidonium majus). Gastroenterology. 1999, 117: 1234-1237. 10.1016/S0016-5085(99)70410-5.View ArticlePubMedGoogle Scholar
- Stickel F, Pöschl G, Seitz HK, Waldherr R, Hahn EG, Schuppan D: Acute hepatitis induced by Greater Celandine (Chelidonium majus). Scand J Gastroenterol. 2003, 38: 565-568. 10.1080/00365520310000942.View ArticlePubMedGoogle Scholar
- Nawrot R, Kalinowski A, Gozdzicka-Jozefiak A: Proteomic analysis of Chelidonium majus milky sap using two-dimensional gel electrophoresis and tandem mass spectrometry. Phytochemistry. 2007, 68: 1612-1622. 10.1016/j.phytochem.2007.03.039.View ArticlePubMedGoogle Scholar
- Nawrot R, Lesniewicz K, Pienkowska J, Gozdzicka-Jozefiak A: A novel extracellular peroxidase and nucleases from a milky sap of Chelidonium majus L. Fitoterapia. 2007, 78: 496-501. 10.1016/j.fitote.2007.04.012.View ArticlePubMedGoogle Scholar
- Nawrot R, Wołuń-Cholewa M, Goździcka-Józefiak A: Nucleases isolated from Chelidonium majus L. milky sap can induce apoptosis in human cervical carcinoma HeLa cells but not in Chinese Hamster Ovary CHO cells. Folia Histochem Cytobiol. 2008, 46: 79-83. 10.2478/v10042-008-0011-x.View ArticlePubMedGoogle Scholar
- Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem. 1951, 193: 265-275.PubMedGoogle Scholar
- Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970, 227: 680-685. 10.1038/227680a0.View ArticlePubMedGoogle Scholar
- Shevchenko A, Wilm M, Vorm O, Mann M: Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem. 1996, 68: 850-858. 10.1021/ac950914h.View ArticlePubMedGoogle Scholar
- Thelen MP, Northcote DH: Identification and purification of a nuclease from Zinnia elegans L.: a potential molecular marker for xylogenesis. Planta. 1989, 179: 181-195. 10.1007/BF00393688.View ArticlePubMedGoogle Scholar
- Ito J, Fukuda H: ZEN1 is a key enzyme in the degradation of nuclear DNA during programmed cell death of tracheary elements. Plant Cell. 2002, 14: 3201-3211. 10.1105/tpc.006411.View ArticlePubMedPubMed CentralGoogle Scholar
- Perkins DN, Pappin DJ, Creasy DM, Cottrell JS: Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis. 1999, 20: 3551-3567. 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2.View ArticlePubMedGoogle Scholar
- Sels J, Mathys J, De Coninck BM, Cammue BP, De Bolle MF: Plant pathogenesis-related (PR) proteins: a focus on PR peptides. Plant Physiol Biochem. 2008, 46: 941-950. 10.1016/j.plaphy.2008.06.011.View ArticlePubMedGoogle Scholar
- Olesen JM, Ehlers BK: Age determination of individuals of Corydalis species and other perennial herbs. Nord J Bot. 2008, 21: 187-194. 10.1111/j.1756-1051.2001.tb01356.x.View ArticleGoogle Scholar
- Maurer HR: Bromelain: biochemistry, pharmacology and medical use. Cell Mol Life Sci. 2001, 58: 1234-1245. 10.1007/PL00000936.View ArticlePubMedGoogle Scholar
- Kienle GS, Glockmann A, Schink M, Kiene H: Viscum album L. extracts in breast and gynaecological cancers: a systematic review of clinical and preclinical research. J Exp Clin Cancer Res. 2009, 28: 79-10.1186/1756-9966-28-79.View ArticlePubMedPubMed CentralGoogle Scholar
- Zhong J, Chau Y: Antitumor activity of a membrane lytic peptide cyclized with a linker sensitive to membrane type 1-matrix metalloproteinase. Mol Cancer Ther. 2008, 7: 2933-2940. 10.1158/1535-7163.MCT-08-0528.View ArticlePubMedGoogle Scholar
- Shai Y: Mode of action of membrane active antimicrobial peptides. Biopolymers. 2002, 66: 236-248. 10.1002/bip.10260.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6882/10/78/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<url>http://creativecommons.org/licenses/by/2.0</url>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.